ReviewCureus2026

Cardiovascular Safety of Next-Generation Antibody-Drug Conjugates in HER2-Low and Triple-Negative Breast Cancer: A Narrative Review (2020-2025).

Rutvik Raval et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.